Health news
On October 13 and 14, 2021, the United States Food and Drug Administration (FDA) held a 2-day virtual public workshop to discuss mandatory opioid prescriber education as part of the Risk Evaluation and Mitigation Strategy…
The Food and Drug Administration (FDA) has granted Fast Track designation to OPNT003 (nasal nalmefene) for the treatment of opioid overdose. OPNT003 is being developed as an alternative to naloxone to reverse the effects of…
The Food and Drug Administration (FDA) has approved Seglentis® (celecoxib and tramadol hydrochloride) for the management of acute pain in adults that is severe enough to require an opioid analgesic and for which alternative treatments…
The Food and Drug Administration (FDA) has approved Zimhi (naloxone hydrochloride) injection for the emergency treatment of known or suspected opioid overdose, as manifested by respiratory and/or central nervous system depression. Zimhi is an opioid…
The Food and Drug Administration (FDA) will be holding a 2-day virtual public workshop to reconsider the need for mandatory opioid prescriber education as part of the Risk Evaluation and Mitigation Strategy (REMS). In 2012,…
© 2005-2021 Top-Meds - All rights reserved. Our website services, content, and products are for informational purposes only. Top-Meds does not provide medical advice, diagnosis, or treatment. | Medical News 2021